• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is transformed small cell lung cancer (SCLC) different from SCLC?

作者信息

Park Cheol-Kyu, Oh In-Jae, Kim Young-Chul

机构信息

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.

Lung and Esophageal Cancer Clinic, Chonnam National University Hwasun Hospital, Jeonnam, Republic of Korea.

出版信息

Transl Cancer Res. 2019 Apr;8(2):346-349. doi: 10.21037/tcr.2019.03.22.

DOI:10.21037/tcr.2019.03.22
PMID:35116765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8799057/
Abstract
摘要

相似文献

1
Is transformed small cell lung cancer (SCLC) different from SCLC?转化型小细胞肺癌（SCLC）与小细胞肺癌有区别吗？
Transl Cancer Res. 2019 Apr;8(2):346-349. doi: 10.21037/tcr.2019.03.22.
2
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.联合型小细胞肺癌与非小细胞肺癌不同组织学成分的临床病理与基因组学比较。
Lung Cancer. 2018 Nov;125:282-290. doi: 10.1016/j.lungcan.2018.10.006. Epub 2018 Oct 9.
3
Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.酪氨酸激酶抑制剂治疗后，联合性小细胞肺癌及肺腺癌来源的小细胞肺癌中的基因改变与蛋白表达
Oncotarget. 2016 Jun 7;7(23):34240-9. doi: 10.18632/oncotarget.9083.
4
A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma.小细胞食管癌、小细胞肺癌及食管腺癌/鳞癌基因表达谱的比较分析
Front Surg. 2021 Jul 30;8:655159. doi: 10.3389/fsurg.2021.655159. eCollection 2021.
5
Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.小细胞肺癌患者初诊时和颅放疗后发生海马转移的风险：预防性或治疗性颅放疗中保护海马的安全性研究。
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):781-6. doi: 10.1016/j.ijrobp.2014.12.026.
6
De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma.从头合成脱氧核苷酸调节小细胞肺癌细胞生长和肿瘤进展。
Sci Rep. 2021 Jun 29;11(1):13474. doi: 10.1038/s41598-021-92948-9.
7
Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer.胰岛素样生长因子结合蛋白-2在小细胞肺癌中的神经内分泌癌特异性上调机制
Am J Pathol. 2009 Sep;175(3):976-87. doi: 10.2353/ajpath.2009.081004. Epub 2009 Aug 13.
8
Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.癌基因激活的小细胞肺癌细胞系中神经内分泌表面抗原的调节
Br J Cancer Suppl. 1991 Jun;14:39-42.
9
Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: a case report and systematic review.基因测序在肺腺癌转化为小细胞肺癌患者中的意义：一例病例报告及系统评价
Transl Cancer Res. 2020 May;9(5):3725-3733. doi: 10.21037/tcr-19-2291.
10
Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate.小细胞肺癌肿瘤细胞诱导调节性 T 淋巴细胞，并且患者的存活与肿瘤浸润中的 FOXP3+细胞呈负相关。
Int J Cancer. 2012 Sep 15;131(6):E928-37. doi: 10.1002/ijc.27613. Epub 2012 May 14.

引用本文的文献

1
Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective study.表皮生长因子受体（EGFR）突变的非小细胞肺癌转变为小细胞肺癌患者的治疗与结局的相关性：一项国际回顾性研究
ESMO Open. 2025 Jun 24;10(7):105326. doi: 10.1016/j.esmoop.2025.105326.
2
Establishment and characterization of BMC-PDC-019: a novel patient-derived cell line of EGFR-mutant pulmonary adenocarcinoma transformed into small-cell lung cancer.BMC-PDC-019的建立与特性研究：一种新型的源自患者的表皮生长因子受体（EGFR）突变型肺腺癌转化为小细胞肺癌的细胞系
Hum Cell. 2023 Nov;36(6):2179-2186. doi: 10.1007/s13577-023-00980-w. Epub 2023 Sep 14.
3
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.Exportin 1 抑制通过下调 SOX2 防止肺和前列腺癌中的神经内分泌转化。
Sci Transl Med. 2023 Aug 2;15(707):eadf7006. doi: 10.1126/scitranslmed.adf7006.
4
Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?在癌症治疗中靶向 EGFR 信号通路：2023 年有哪些新进展？
Expert Opin Ther Targets. 2023 Apr-May;27(4-5):305-324. doi: 10.1080/14728222.2023.2218613. Epub 2023 Jun 2.
5
Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer.基于患者来源的细胞的药物基因组学评估，以揭示晚期肺癌的潜在耐药机制和新的治疗方法。
J Exp Clin Cancer Res. 2023 Jan 30;42(1):37. doi: 10.1186/s13046-023-02606-3.
6
Histologic transformation in lung cancer: when one door shuts, another opens.肺癌中的组织学转化：当一扇门关闭时，另一扇门打开。
Ther Adv Med Oncol. 2022 Oct 14;14:17588359221130503. doi: 10.1177/17588359221130503. eCollection 2022.
7
An EGFR-mutant lung adenocarcinoma that transformed into small-cell lung cancer. A case report.一例转化为小细胞肺癌的表皮生长因子受体（EGFR）突变型肺腺癌。病例报告。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Dec;166(4):451-454. doi: 10.5507/bp.2022.037. Epub 2022 Aug 23.
8
Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer.非小细胞肺癌向小细胞肺癌转化作为肺癌对酪氨酸激酶抑制剂耐药的机制
Cancer Drug Resist. 2020 Feb 28;3(2):171-178. doi: 10.20517/cdr.2019.85. eCollection 2020.
9
RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAs.小细胞肺癌的RNA测序分析揭示了化疗不敏感的长链非编码RNA和微小RNA候选分子。
Ann Transl Med. 2020 Feb;8(4):121. doi: 10.21037/atm.2020.01.75.

本文引用的文献

1
Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is Needed.雄激素剥夺治疗下前列腺腺癌向小细胞神经内分泌癌的转化：已取得诸多成果，但仍需更多信息。
J Clin Oncol. 2019 Feb 1;37(4):350-351. doi: 10.1200/JCO.18.01055. Epub 2018 Dec 17.
2
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.表皮生长因子受体突变型腺癌转化为小细胞肺癌和其他神经内分泌癌：临床结局。
J Clin Oncol. 2019 Feb 1;37(4):278-285. doi: 10.1200/JCO.18.01585. Epub 2018 Dec 14.
3
Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.小细胞肺癌转化作为KRAS突变型肺腺癌对PD-1治疗耐药的一种机制：两例报告
J Thorac Oncol. 2019 Mar;14(3):e45-e48. doi: 10.1016/j.jtho.2018.11.031. Epub 2018 Dec 10.
4
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation.非小细胞肺癌向小细胞肺癌转化与PD-1抑制剂：两例潜在组织学转化病例
Lung Cancer (Auckl). 2018 Oct 25;9:85-90. doi: 10.2147/LCTT.S173724. eCollection 2018.
5
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics.从非小细胞肺癌到小细胞肺癌的转化：分子和治疗特征简述。
J Thorac Oncol. 2019 Jan;14(1):130-134. doi: 10.1016/j.jtho.2018.08.2028. Epub 2018 Sep 11.
6
Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with rearrangement-positive non-small cell lung cancer: A case report.血清ProGRP和NSE水平预测重排阳性非小细胞肺癌患者发生小细胞肺癌转化：一例报告
Oncol Lett. 2018 Oct;16(4):4219-4222. doi: 10.3892/ol.2018.9158. Epub 2018 Jul 17.
7
Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma.肿瘤病理转化的分子机制及其临床意义：肺腺癌转化为小细胞癌的预测因素
J Thorac Dis. 2017 Oct;9(10):3469-3472. doi: 10.21037/jtd.2017.09.15.
8
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.酪氨酸激酶抑制剂治疗后发生小细胞肺癌转化的肺腺癌患者的结局：系统评价和汇总分析。
Cancer Treat Rev. 2017 Sep;59:117-122. doi: 10.1016/j.ctrv.2017.07.007. Epub 2017 Jul 31.
9
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.肺腺癌演变为小细胞癌的克隆进化史和遗传预测因子。
J Clin Oncol. 2017 Sep 10;35(26):3065-3074. doi: 10.1200/JCO.2016.71.9096. Epub 2017 May 12.
10
Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors.间变性淋巴瘤激酶（ALK）重排腺癌组织学转化为小细胞肺癌：一种对ALK抑制剂耐药的新机制。
Lung Cancer. 2016 Dec;102:38-41. doi: 10.1016/j.lungcan.2016.10.012. Epub 2016 Oct 27.